Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
FDA Forces the Only Drug for Preterm Births to Leave Market
Health Makena injections for pregnant women with previous early births are ineffective, agency says Source link
Medicare Cracks Down on Deceptive Advertising, Service Denials by Privately-Run Plans
Health Rule comes after the federal health-insurance program faced criticism that Medicare Advantage plans were running misleading ads Source link
Johnson & Johnson Proposes Paying $9 Billion to Settle Talc Lawsuits
A unit of the health-products company is also refiling for bankruptcy protection to seek approval for the settlement plan. Source link
FTC Rejects Illumina's $7 Billion Deal for Cancer-Test Developer Grail
The agency said the combination would hurt competition for cancer-detection tests while raising prices. Source link
The 'King Kong' of Weight-Loss Drugs Is Coming
Eli Lilly’s Mounjaro could outpace Ozempic as the most powerful treatment on the market. To develop it, the drug company needed to overhaul long-held but
Dreaded Medical Paperwork Required by Health Insurers to Be Trimmed
WSJ News Exclusive Health UnitedHealthcare, Cigna and Aetna move to revamp prior-authorization programs Source link
Americans to Be Barred From Buying Ozempic in British Columbia
Provincial health officials urged doctors and pharmacists to make sure people are taking the drug to treat diabetes, not lose weight. Source link
Former Aetna CEO to Take Helm of Health Insurer Oscar
WSJ News Exclusive Health Mark Bertolini was most recently the co-chief executive of hedge fund Bridgewater Associates Source link
Drug Middlemen Accused of Price Fixing by Ohio Attorney General
The state’s lawsuit alleged certain pharmacy-benefit managers shared drug pricing and other information to gain leverage during rebate negotiations with pharmaceutical companies. Source link